Jason Werner

Jason Werner is currently serving as a Board Member at Alimera Sciences, InflammX Therapeutics Inc., and SightStream Biotherapeutics. Prior to this, he was the President and CEO at SightStream Biotherapeutics. He has held various leadership roles in companies such as Eyevance Pharmaceuticals, SUN PHARMA, and Foresight Biotherapeutics, gaining extensive experience in strategy, commercial development, and M&A. Jason also has a background in consulting and new product planning in the pharmaceutical industry. He holds a Bachelor of Science in Business Administration from UNH Peter T. Paul College of Business and Economics. Additionally, he has completed a Certificate in Strategic Decision and Risk Management from Stanford University Center for Professional Development.